Case Report
Accepted on 27 Feb 2025
Case report: successful immune checkpoint inhibitor rechallenge after Sintilimab-induced Guillain-Barré Syndrome
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 27 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 27 Feb 2025
in Environmental Health and Exposome
Original Research
Accepted on 27 Feb 2025
in Food Microbiology
Original Research
Accepted on 27 Feb 2025
in Natural Language Processing
Original Research
Accepted on 27 Feb 2025
in Environmental Health and Exposome
Original Research
Accepted on 27 Feb 2025
in Inflammation Pharmacology
Original Research
Accepted on 27 Feb 2025
in Computational Physiology and Medicine
Review
Accepted on 27 Feb 2025
in Intestinal Microbiome
Original Research
Accepted on 27 Feb 2025
in Intestinal Microbiome
Original Research
Accepted on 27 Feb 2025
Original Research
Accepted on 27 Feb 2025
in Cardiovascular Endocrinology
Original Research
Accepted on 27 Feb 2025
in Perception Science
Original Research
Accepted on 27 Feb 2025
in Personality and Social Psychology
Original Research
Accepted on 27 Feb 2025
in Forest Management
Original Research
Accepted on 27 Feb 2025
in Public Health Education and Promotion
Original Research
Accepted on 27 Feb 2025
in Clinical Infectious Diseases